Molecular Mechanisms of Estrogen Carcinogenesis
暂无分享,去创建一个
[1] J. Liehr,et al. Microsome-mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: correlation of DNA damage by free radicals with metabolic activation to quinones. , 1995, Carcinogenesis.
[2] J. Liehr,et al. Induction by estrogens of lipid peroxidation and lipid peroxide-derived malonaldehyde-DNA adducts in male Syrian hamsters: role of lipid peroxidation in estrogen-induced kidney carcinogenesis. , 1995, Carcinogenesis.
[3] S. Ethier. Growth factor synthesis and human breast cancer progression. , 1995, Journal of the National Cancer Institute.
[4] C M King,et al. Tamoxifen and the induction of cancer. , 1995, Carcinogenesis.
[5] L. Gray,et al. Persistent DDT metabolite p,p'DDE is a potent androgen receptor antagonist , 1995, Nature.
[6] G. Clark,et al. Rat CYP1B1: an adrenal cytochrome P450 that exhibits sex-dependent expression in livers and kidneys of TCDD-treated animals. , 1995, Carcinogenesis.
[7] D. Roy,et al. Activation of phosphorylation of plasma membrane insulin-like growth factor-I receptors in the kidney of Syrian hamsters by diethylstilbestrol. , 1995, Carcinogenesis.
[8] R. Guzman,et al. Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[9] S. Hirohashi,et al. 8-hydroxydeoxyguanosine levels in DNA of human breast cancer are not significantly different from those of non-cancerous breast tissues by the HPLC-ECD method. , 1995, Cancer letters.
[10] E. Ohtsuka,et al. 8-Hydroxyguanine (7,8-dihydro-8-oxoguanine) in hot spots of the c-Ha-ras gene: effects of sequence contexts on mutation spectra. , 1995, Carcinogenesis.
[11] S. Safe,et al. Environmental and dietary estrogens and human health: is there a problem? , 1995, Environmental health perspectives.
[12] J. Zweier,et al. ESR evidence for the generation of reactive oxygen species from the copper-mediated oxidation of the benzene metabolite, hydroquinone: role in DNA damage. , 1995, Chemico-biological interactions.
[13] J. Liehr,et al. Lipid hydroperoxide-induced endogenous DNA adducts in hamsters: possible mechanism of lipid hydroperoxide-mediated carcinogenesis. , 1995, Archives of biochemistry and biophysics.
[14] D. Roy,et al. Catalysis of the oxidation and reduction reactions of steroid and stilbene estrogens by nuclear enzymes. , 1994, Archives of biochemistry and biophysics.
[15] J. Li,et al. Induction of chromosome aberrations in Syrian hamster renal cortical cells by various estrogens. , 1994, Mutation research.
[16] J. Liehr,et al. 8-Hydroxylation of guanine bases in kidney and liver DNA of hamsters treated with estradiol: role of free radicals in estrogen-induced carcinogenesis. , 1994, Cancer research.
[17] G. Lucier,et al. Growth stimulation followed by growth inhibition in livers of female rats treated with ethinyl estradiol. , 1994, Carcinogenesis.
[18] D. Miller,et al. Long-term responses of women to indole-3-carbinol or a high fiber diet. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[19] L. Nutter,et al. Cellular biochemical determinants modulating the metabolism of estrone 3,4-quinone. , 1994, Chemical research in toxicology.
[20] H. Bradlow,et al. Alterations in estradiol metabolism in MCF-7 cells induced by treatment with indole-3-carbinol and related compounds , 1994, Steroids.
[21] E. Cavalieri. Minisymposium on Endogenous Carcinogens: The Catechol Estrogen Pathway. An Introduction , 1994 .
[22] J. Yager,et al. DNA damage caused by reactive oxygen species originating from a copper-dependent oxidation of the 2-hydroxy catechol of estradiol. , 1994, Carcinogenesis.
[23] E. Jabs,et al. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. , 1994, The Journal of biological chemistry.
[24] J. Liehr,et al. DNA single-strand breaks in kidneys of Syrian hamsters treated with steroidal estrogens: hormone-induced free radical damage preceding renal malignancy. , 1994, Carcinogenesis.
[25] M. Osborne,et al. Catechol estrogen production in rat microsomes after treatment with indole-3-carbinol, ascorbigen, or β-naphthaflavone: A comparison of stable isotope dilution gas chromatography-mass spectrometry and radiometric methods , 1994, Steroids.
[26] B. Macmahon. Pesticide residues and breast cancer? , 1994, Journal of the National Cancer Institute.
[27] J. Liehr,et al. Quercetin increases the severity of estradiol-induced tumorigenesis in hamster kidney. , 1994, Toxicology and applied pharmacology.
[28] L. Nutter,et al. An o-quinone form of estrogen produces free radicals in human breast cancer cells: correlation with DNA damage. , 1994, Chemical research in toxicology.
[29] D. Nebert,et al. Elevated estrogen 16 alpha-hydroxylase activity: is this a genotoxic or nongenotoxic biomarker in human breast cancer risk? , 1993, Journal of the National Cancer Institute.
[30] R. Korah,et al. Mutagenic and recombinagenic effects of diethylstilbestrol quinone. , 1993, Mutation research.
[31] L. Sheffield,et al. Estrogen enhances epidermal growth factor‐induced DNA synthesis in mammary epithelial cells , 1993, Journal of cellular physiology.
[32] M. Trush,et al. DNA damage resulting from the oxidation of hydroquinone by copper: role for a Cu(II)/Cu(I) redox cycle and reactive oxygen generation. , 1993, Carcinogenesis.
[33] M. Gould. Cellular and molecular aspects of the multistage progression of mammary carcinogenesis in humans and rats. , 1993, Seminars in cancer biology.
[34] N. Polissar,et al. The etiology of breast cancer characteristic alterations in hydroxyl radical‐induced dna base lesions during oncogenesis with potential for evaluating incidence risk , 1993, Cancer.
[35] J. Liehr,et al. Microsomal hydroxylation of 2- and 4-fluoroestradiol to catechol metabolites and their conversion to methyl ethers: catechol estrogens as possible mediators of hormonal carcinogenesis. , 1993, Molecular pharmacology.
[36] B. E. Walker,et al. Pituitary tumors in mice exposed prenatally to diethylstilbestrol. , 1993, Cancer research.
[37] Y. Osawa,et al. Multiple functions of aromatase and the active site structure; aromatase is the placental estrogen 2-hydroxylase , 1993, The Journal of Steroid Biochemistry and Molecular Biology.
[38] M. Osborne,et al. Genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. , 1993, Recent progress in hormone research.
[39] C. Martucci,et al. P450 enzymes of estrogen metabolism. , 1993, Pharmacology & therapeutics.
[40] M. Trush,et al. Oxidation of hydroquinone by copper: chemical mechanism and biological effects. , 1993, Archives of biochemistry and biophysics.
[41] R. Davies,et al. Ethinyl estradiol-induced cell proliferation in rat liver. Involvement of specific populations of hepatocytes. , 1992, Carcinogenesis.
[42] J. Doroshow,et al. Copper-dependent site-specific mutagenesis by benzoyl peroxide in the supF gene of the mutation reporter plasmid pS189. , 1992, Carcinogenesis.
[43] J. D. Frank,et al. Studies of early hepatocellular proliferation and peroxisomal proliferation in Sprague-Dawley rats treated with tumorigenic doses of clofibrate. , 1992, Toxicology and applied pharmacology.
[44] K. El-Bayoumy. Environmental carcinogens that may be involved in human breast cancer etiology. , 1992, Chemical research in toxicology.
[45] H. Strobel,et al. Catalysis of the oxidation of steroid and stilbene estrogens to estrogen quinone metabolites by the beta-naphthoflavone-inducible cytochrome P450 IA family. , 1992, Archives of biochemistry and biophysics.
[46] R. Mizumoto,et al. 32P‐Postlabeling Analysis of DNA Adducts in Rats during Estrogen‐induced Hepatocarcinogenesis and Effect of Tamoxifen on DNA Adduct Level , 1992, Japanese journal of cancer research : Gann.
[47] M. Metzler,et al. Interactions of Carcinogenic Estrogens with Microtubular Proteins , 1992 .
[48] J. Fishman,et al. Differential Interactions of Estradiol Metabolites with the Estrogen Receptor: Genomic Consequences and Tumorigenesis , 1992 .
[49] SaraAntonia Li,et al. Synthetic Estrogens and Liver Cancer: Risk Analysis of Animal and Human Data , 1992 .
[50] H. Bern. Diethylstilbestrol (DES) Syndrome: Present Status of Animal and Human Studies , 1992 .
[51] A. Wang,et al. Covalent modification of guanine bases in double-stranded DNA. The 1.2-A Z-DNA structure of d(CGCGCG) in the presence of CuCl2. , 1992, The Journal of biological chemistry.
[52] J. Yager,et al. Sex Hormones and Tumor Promotion in Liver , 1991, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[53] G. Quigley,et al. Base-specific binding of copper(II) to Z-DNA. The 1.3-A single crystal structure of d(m5CGUAm5CG) in the presence of CuCl2. , 1991, The Journal of biological chemistry.
[54] D. Roy,et al. Xanthine oxidase-catalyzed reduction of estrogen quinones to semiquinones and hydroquinones. , 1991, Biochemical pharmacology.
[55] L. Nutter,et al. Characterization of DNA damage induced by 3,4-estrone-o-quinone in human cells. , 1991, The Journal of biological chemistry.
[56] G. Michalopoulos,et al. Long-term treatment with hepatic tumor promoters inhibits mitogenic responses of hepatocytes to acidic fibroblast growth factor and hepatocyte growth factor. , 1991, Cancer letters.
[57] J. Liehr,et al. Elevated 8-hydroxydeoxyguanosine levels in DNA of diethylstilbestrol-treated Syrian hamsters: covalent DNA damage by free radicals generated by redox cycling of diethylstilbestrol. , 1991, Cancer research.
[58] T. Nambara,et al. Structure of the adduct of 16α-hydroxyestrone with a primary amine: evidence for the heyns rearrangement of steroidal D-ring α-hydroxyimines , 1991, Steroids.
[59] T. Shimada,et al. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. , 1991, Chemical research in toxicology.
[60] W. Schulz,et al. Formation of 8-hydroxy(deoxy)guanosine and generation of strand breaks at guanine residues in DNA by singlet oxygen. , 1991, Biochemistry.
[61] J. Liehr,et al. Transplacental genotoxicity of diethylstilbestrol. , 1991, Carcinogenesis.
[62] H. Strobel,et al. Cytochrome b5-mediated redox cycling of estrogen. , 1991, Archives of biochemistry and biophysics.
[63] J. Zweier,et al. Role of the benzoyloxyl radical in DNA damage mediated by benzoyl peroxide. , 1991, Chemical research in toxicology.
[64] J. McLachlan,et al. Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis. , 1990, Cancer research.
[65] M. Metzler,et al. Covalent binding of reactive estrogen metabolites to microtubular protein as a possible mechanism of aneuploidy induction and neoplastic cell transformation. , 1990, Environmental health perspectives.
[66] J. Yager,et al. Regulation of rat hepatocyte epidermal growth factor receptor by the liver tumor promoter ethinyl estradiol. , 1990, Carcinogenesis.
[67] K. Ishak,et al. Estrogen induction of hepatocellular carcinomas in Armenian hamsters , 1990, Hepatology.
[68] J. Barrett,et al. Aneuploidy induction in human fibroblasts: comparison with results in Syrian hamster fibroblasts. , 1990, Mutation research.
[69] S. Shapiro,et al. Oral contraceptive use and liver cancer. , 1989, American journal of epidemiology.
[70] J. Liehr,et al. Mechanism of genotoxicity of diethylstilbestrol in vivo. , 1989, The Journal of biological chemistry.
[71] J. Yager,et al. Effects of the liver tumor promoter ethinyl estradiol on epidermal growth factor-induced DNA synthesis and epidermal growth factor receptor levels in cultured rat hepatocytes. , 1989, Cancer research.
[72] J. Wittliff,et al. Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancers. , 1989, Journal of steroid biochemistry.
[73] V. Mazzaferro,et al. The effect of estrogen and tamoxifen on hepatocyte proliferation in Vivo and in Vitro , 1989, Hepatology.
[74] S. Goldfarb,et al. Specific estrogen-induced cell proliferation of cultured Syrian hamster renal proximal tubular cells in serum-free chemically defined media. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[75] J. Li,et al. Morphological and immunohistochemical studies of the estrogen-induced Syrian hamster renal tumor: probable cell of origin. , 1989, Cancer research.
[76] J. Weisz,et al. Monooxygenase mediating catecholestrogen formation by rat anterior pituitary is an estrogen-4-hydroxylase. , 1989, Endocrinology.
[77] G. Talukder,et al. Effects of copper on mammalian cell components. , 1989, Chemico-biological interactions.
[78] I. Leav,et al. Androgen‐supported estrogen‐enhanced epithelial proliferation in the prostates of intact noble rats , 1989, The Prostate.
[79] R. Jirtle,et al. Phenobarbital reduces EGF receptors and the ability of physiological concentrations of calcium to suppress hepatocyte proliferation. , 1988, Carcinogenesis.
[80] J. Liehr,et al. Histochemical analysis of the development of estradiol-induced kidney tumors in male Syrian hamsters. , 1988, Cancer research.
[81] M. Metzler,et al. Site-specific covalent binding of stilbene-type and steroidal estrogens to tubulin following metabolic activation in vitro. , 1987, Carcinogenesis.
[82] J. Yager,et al. Effects of ethinyl estradiol and tamoxifen on liver DNA turnover and new synthesis and appearance of gamma glutamyl transpeptidase-positive foci in female rats. , 1986, Carcinogenesis.
[83] J. Barrett,et al. Alteration in diethylstilbestrol-induced mutagenicity and cell transformation by exogenous metabolic activation. , 1986, Carcinogenesis.
[84] H. Bradlow,et al. 16α‐Hydroxylation of Estradiol: A Possible Risk Marker for Breast Cancer , 1986 .
[85] R. Schulte‐Hermann,et al. Effect of tumor promoting contraceptive steroids on growth and drug metabolizing enzymes in rat liver. , 1986, Cancer research.
[86] H. Adlercreutz,et al. Urinary estrogen profile determination in young Finnish vegetarian and omnivorous women. , 1986, Journal of Steroid Biochemistry.
[87] M. Metzler,et al. Co-oxidation of diethylstilbestrol and structural analogs by prostaglandin synthase. , 1986, Carcinogenesis.
[88] J. Liehr,et al. Carcinogenicity of catechol estrogens in Syrian hamsters. , 1986, Journal of steroid biochemistry.
[89] H. Bradlow,et al. Estradiol 16 alpha-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[90] K. Yokoro,et al. Inhibition by 3-amino-1H-1,2,4-triazole of hepatic tumorigenesis induced by diethylstilbestrol alone or combined with N-nitrosobutylurea in WF rats. , 1985, Journal of the National Cancer Institute.
[91] J. Li,et al. Estrogen 2- and 4-hydroxylase activity, catechol estrogen formation, and implications for estrogen carcinogenesis in the hamster kidney. , 1985, Cancer research.
[92] J. Yager,et al. Enhancement of hepatocarcinogenesis in female rats by ethinyl estradiol and mestranol but not estradiol. , 1984, Cancer research.
[93] J. Li,et al. High incidence of hepatocellular carcinomas after synthetic estrogen administration in Syrian golden hamsters fed alpha-naphthoflavone: a new tumor model. , 1984, Journal of the National Cancer Institute.
[94] H. Bradlow,et al. Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. , 1984, The Journal of biological chemistry.
[95] K. Yokoro,et al. Inhibitory effect of antiestrogen on hepatic tumorigenesis in WF rats treated with diethylstilbestrol alone or in combination with N-nitrosobutylurea. , 1984, Journal of the National Cancer Institute.
[96] J. Henkin,et al. Diethylstilbestrol (DES) quinone: a reactive intermediate in DES metabolism. , 1983, Biochemical pharmacology.
[97] J. Li,et al. Relative carcinogenic activity of various synthetic and natural estrogens in the Syrian hamster kidney. , 1983, Cancer research.
[98] J. Barrett,et al. Aneuploidy induction and cell transformation by diethylstilbestrol: a possible chromosomal mechanism in carcinogenesis. , 1983, Cancer research.
[99] F. Naftolin,et al. Kinetics of catechol estrogen-estrogen receptor dissociation: A possible factor underlying differences in catechol estrogen biological activity , 1983, Steroids.
[100] H. Barbason,et al. Promotion mechanism of phenobarbital and partial hepatectomy in DENA hepatocarcinogenesis cell kinetics effect. , 1983, British Journal of Cancer.
[101] R. Bucala,et al. Formation of covalent adducts between cortisol and 16 alpha-hydroxyestrone and protein: possible role in the pathogenesis of cortisol toxicity and systemic lupus erythematosus. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[102] J. Yager,et al. Lack of hepatogenotoxicity of oral contraceptive steroids. , 1982, Carcinogenesis.
[103] J. Barrett,et al. Diethylstilbestrol induces neoplastic transformation without measurable gene mutation at two loci. , 1981, Science.
[104] R. A. Huseby. Demonstration of a direct carcinogenic effect of estradiol on Leydig cells of the mouse. , 1980, Cancer research.
[105] L. Jones,et al. Transplantability and sex steroid hormone responsiveness of cervicovaginal tumors derived from female BALB/cCrgl mice neonatally treated with ovarian steroids. , 1979, Cancer research.
[106] D. Casciano,et al. Metabolism of 17α‐ethynylestradiol by intact liver parenchymal cells isolated from mouse and rat , 1977 .
[107] D. Sirbasku,et al. Control of cell growth. IV. Growth properties of a new cell line established from an estrogen-dependent kidney tumor of the Syrian hamster. , 1976, Endocrinology.
[108] H. Kirkman. Estrogen-induced tumors of the kidney. IV. Incidence in female Syrian hamsters. , 1959, National Cancer Institute monograph.
[109] H. Kirkman,et al. Estrogen-induced tumors of the kidney. V. Histology and histogenesis in the Syrian hamster. , 1959, National Cancer Institute monograph.